Ritedose Pharmaceuticals Gains FDA Green Light for New Albuterol Inhalation Solution amid Drug Shortage Crisis Ritedose Pharmaceuticals has received FDA approval for a new Albuterol Inhalation Solution. This comes in the wake of a nationwide shortage of essential asthma medication.

Ritedose Pharmaceuticals Gains FDA Green Light for New Albuterol Inhalation Solution amid Drug Shortage Crisis #United_States #FDA_Approval #Columbia,_South_Carolina #Ritedose #Albuterol

Ritedose Boosts Production Capacity with New Syntegon Packaging Line for COPD Drug Ohtuvayre Ritedose is enhancing its manufacturing capabilities by adding a seventh Syntegon packaging line to produce single vial medications, especially for the COPD drug Ohtuvayre.

Ritedose Boosts Production Capacity with New Syntegon Packaging Line for COPD Drug Ohtuvayre #United_States #Columbia #Ritedose #Ohtuvayre #Syntegon

Ritedose Launches 1,000 Hours of Purpose to Serve Local Communities Ritedose announces its new initiative, 1,000 Hours of Purpose, allowing employees to volunteer and support local nonprofits in the Midlands.

Ritedose Launches 1,000 Hours of Purpose to Serve Local Communities #United_States #United_Way #Columbia #Ritedose #Midlands

Strategic Partnership to Enhance Pharmaceutical Manufacturing Skills in South Carolina Ritedose Corporation collaborates with Newberry College to launch a specialized Pharmaceutical Manufacturing program in South Carolina, addressing workforce needs.

Strategic Partnership to Enhance Pharmaceutical Manufacturing Skills in South Carolina #United_States #Columbia #Pharmaceutical_Manufacturing #Ritedose #Newberry_College